Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Lantheus Holdings, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Lantheus Holdings, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Lantheus Holdings, Inc.
SIC 2835 · In Vitro & In Vivo Diagnostic Substances
Notes
Support
about
terms
$
LNTH
Lantheus Holdings, Inc.
CIK:
0001521036
|
SEC Filings
ARTICLES AND BYLAWS
EX-3.1
d16067dex31.htm
2026-05-01T00:00:00Z
EX-3.2
d20698dex32.htm
2025-05-05T00:00:00Z
EX-3.2
d423986dex32.htm
2022-12-28T00:00:00Z
EX-3.2
d264178dex32.htm
2021-12-27T00:00:00Z
EX-3.2
d653114dex32.htm
2018-04-27T00:00:00Z
EX-3.1
d653114dex31.htm
2018-04-27T00:00:00Z
EX-3.2
d38431dex32.htm
2015-06-30T00:00:00Z
EX-3.1
d38431dex31.htm
2015-06-30T00:00:00Z
EX-3.1
d715471dex31.htm
2014-06-24T00:00:00Z
EX-3.2
d715471dex32.htm
2014-06-24T00:00:00Z